Antigen-independent immune responses after dendritic cell vaccination

Cancer Immunology, Immunotherapy

Volumn 56, Issue 6, 2007, Pages 897-903

  Leonhartsberger, Nicolai ^a   Ramoner, Reinhold ^a   Putz, Thomas ^a   Gander, Hubert ^a   Rahm, Andrea ^a   Falkensammer, Claudia ^a   Bartsch, Georg ^a   Thurnher, Martin ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

BCG; Dendritic cell vaccination; IL 15; IL 7; LPS; Renal cancer

Indexed keywords

CD83 ANTIGEN; DENDRITIC CELL VACCINE; INTERLEUKIN 15; INTERLEUKIN 7; KEYHOLE LIMPET HEMOCYANIN; LIPOPOLYSACCHARIDE;

ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNIZATION; CANCER PATIENT; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENTIATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KIDNEY CARCINOMA; MEMORY T LYMPHOCYTE; METASTASIS; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

CANCER VACCINES; CARCINOMA, RENAL CELL; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-15; INTERLEUKIN-7; KIDNEY NEOPLASMS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES;

EID: 34248141198     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-006-0245-4     Document Type: Article

References (21)

1. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
2. Banchereau J, Palucka AK (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296-306
3. Brossart P, Wirths S, Stuhler G, Reichardt VL, Kanz L, Brugger W (2000) Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96:3102-3108
4. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9:1484-1490
5. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ (2004) Dendritic cell immunotherapy: mapping the way. Nat Med 10:475-480
6. Geginat J, Sallusto F, Lanzavecchia A (2001) Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 194:1711-1719
7. Gilliet M, Kleinhans M, Lantelme E, Schadendorf D, Burg G, Nestle FO (2003) Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood 102:36-42
8. Holtl L, Rieser C, Papesh C, Ramoner R, Bartsch G, Thurnher M (1998) CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet 352:1358
9. Holtl L, Zelle-Rieser C, Gander H, Papesh C, Ramoner R, Bartsch G, Rogatsch H, Barsoum AL, Coggin JH Jr, Thurnher M (2002) Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res 8:3369-3376
10. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52-58
11. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995
12. Lanzavecchia A, Sallusto F (2005) Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 17:326-332
13. Marten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, Caspari R, Flieger D, HanXand P, Von Ruecker A, Eis-Hubinger AM, Muller S, Schwaner I, Lohmann U, Heylmann G, Sauerbruch T, Schmidt-Wolf IG (2003) Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther 14:483-494
14. Mattern T, Thanhauser A, Reiling N, Toellner KM, Duchrow M, Kusumoto S, Rietschel ET, Ernst M, Brade H, Flad HD et al (1994) Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol 153:2996-3004
15. Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116:180-183
16. Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15:138-147
17. Surh CD, Sprent J (2005) Regulation of mature T cell homeostasis. Semin Immunol 17:183-191
18. Thurnher M, Ramoner R, Gastl G, Radmayr C, Bock G, Herold M, Klocker H, Bartsch G (1997) Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells. Int J Cancer 70:128-134
19. Tough DF, Sun S, Sprent J (1997) T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 185:2089-2094
20. Ulevitch RJ, Tobias PS (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13:437-457
21. Wierecky J, Muller MR, Wirths S, Halder-Oehler E, Dorfel D, Schmidt SM, Hantschel M, Brugger W, Schroder S, Horger MS, Kanz L, Brossart P (2006) Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res 66:5910-5918